HUMAN CHORIONIC GONADOTROPIN BETA (BHCG) - TUMOR MARKER/CONGENITAL DISORDERS - ANVISA Registration 10033121048

Access comprehensive regulatory information for HUMAN CHORIONIC GONADOTROPIN BETA (BHCG) - TUMOR MARKER/CONGENITAL DISORDERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10033121048 and manufactured by BECKMAN COULTER INC. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until Jul 03, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, B-R-A-H-M-S GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.